Glazer Capital LLC’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Glazer Capital LLC’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-211,079	Closed	-$7.95M	–	1088
2021 Q1	$7.95M	Buy	+211,079	New	+$5.26M	0.11%	250

Glazer Capital LLC's FPRX Position: Q2 2021 in Review

Glazer Capital LLC sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 211,079 shares — an estimated $7.95M sold.

Glazer Capital LLC first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $7.95M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Glazer Capital LLC reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Glazer Capital LLC sold 211,079 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $7.95M.
Glazer Capital LLC first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Glazer Capital LLC's Five Prime Therapeutics, Inc. position peaked at $7.95M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Glazer Capital LLC's 13F filing for Q2 2021, filed 13 Aug 2021.